RAPT Therapeutics(RAPT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 RAPT Therapeutics Reports Second Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif. – August 8, 2024 – RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunologybased therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today reported financial results for the second quarter and six months ended June 30, 2024. "We continue to analyze the data fr ...